NDC 13537-303-01 - ESIKA Extreme Moisturizing SPF 16
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13537-303
- Requested NDC
- 13537-303-01
- Package NDCs from labels
- 13537-303-01, 13537-303-02
- Manufacturer
- Ventura Corporation (San Juan, P.R) | Bel Star S.A. (Colombia)
- Effective date
- 2011-05-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| OCTINOXATE - Ventura Corporation (San Juan, P.R) | Bel Star S.A. (Colombia) | Ventura Corporation (San Juan, P.R) | Bel Star S.A. (Colombia) | 2011-05-18 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 13537-303-02 | 2025-05-06 | C162847 | 48780-1 | 960f7f55-c18b-8e05-e053-dbdaa90a074a | ēsika Extreme Moisturizing Lipstick SPF 16 |
| 13537-303-02 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c18b-8e05-e053-dbdaa90a074a | ēsika Extreme Moisturizing Lipstick SPF 16 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Meijer Distribution Inc. | 03c46823-0b1f-4101-e063-6294a90aaf94 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS NO TOUCH SPRAY | Premier Brands of America Inc. | 36481d67-2346-470b-e063-6294a90aae99 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Chain Drug Marketing Association Inc | 1a3f8819-58cf-8923-e063-6394a90a37af | 2026-11-04 | Warnings | 1K09F3G675 |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-11-04 | Warnings | PDC6A3C0OX |
| Lemon Glycerine Swabsticks | GLYCERINE | PHOENIX HEALTHCARE SOLUTIONS, LLC | 436919f7-14cd-4318-9388-b3e1cbec176b | 2026-11-03 | Warnings | PDC6A3C0OX |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Shield Line LLC | 5f627926-b8de-c02a-e063-6294a90aa7a5 | 2026-11-03 | Warnings | 4T6H12BN9U |
| hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Shield Line LLC | 5f635795-cb5b-cab4-e063-6394a90a7a9a | 2026-11-03 | Warnings | 4T6H12BN9U PDC6A3C0OX |
| Skin Balancing Ultra Sheer Daily Defence SPF 30 Paulas Choice | AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OXYBENZONE | Cosmetic Enterprises Ltd | 3bf31626-5580-457b-8a59-cc37f4ab0767 | 2026-11-03 | Warnings | 95OOS7VE0Y |
| SPF 50 Face Sunscreen Bioelements | AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE | Cosmetic Enterprises Ltd | 498b16c8-ba54-4a0a-8dbc-4b5cc368e214 | 2026-11-03 | Warnings | 95OOS7VE0Y 4Y5P7MUD51 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 8bae6f0f-58ca-490f-a725-8ec4bc6ba514 | 2026-11-03 | Warnings, Adverse reactions | 660YQ98I10 |
| Huddle Barrier Balm | GLYCERIN | Better Barrier Co. | 5b3cf1ed-082b-15cf-e063-6394a90a688e | 2026-11-02 | Warnings | PDC6A3C0OX |
| HERA SILKYSTAY FOUNDATION 34W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f3ef340-c68e-1790-e063-6394a90a44aa | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 35C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f40c97f-b90e-bec7-e063-6394a90ae5db | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 35N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f40f46b-c6b2-df1f-e063-6394a90afd96 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 37W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4105f3-d08b-edb5-e063-6394a90ad28b | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 39N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f41120a-521a-f5ac-e063-6394a90ac021 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 41W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4158f0-c743-29c2-e063-6394a90ac721 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 43N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f41ecb2-9fe5-ade7-e063-6294a90abc4e | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 43O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f425415-ed84-fc33-e063-6394a90a15f7 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 44C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f42d960-6b86-b4cd-e063-6294a90a98f3 | 2026-11-01 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.